Sleepose

Basic Sleepose information

• INN (international nonproprietary name): Melatonin.
• ATC code: N05CH01.
• Forms and dosages: disintegrating tablet (DT) containing melatonin 20 mg per tablet.
• OTC / Rx classification: melatonin is a prescription-only medicine (POM) in the UK.

Legal status and availability in the UK

Circadin is prescription-only in the UK and is the licensed melatonin product commonly prescribed for older adults.

In our online pharmacy, Sleepose is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Clinical effectiveness in the UK

Who benefits from melatonin in UK practice?

NHS pathways favour non-pharmacological first-line care such as CBT‑I and sleep hygiene advice.

Where medicines are used, Circadin 2 mg prolonged-release is the licensed prescription option for older adults.

Melatonin can provide meaningful subjective benefits for sleep onset and perceived sleep quality.

Benefits are usually greater when melatonin is linked with behavioural measures such as routine and light exposure control.

Effectiveness varies, and some people have residual daytime sleepiness.

Private clinics sometimes prescribe higher doses for circadian disorders; practice varies by clinician.

Sleepose 20 Tablet DT at 20 mg would be atypical in UK prescribing and likely considered off‑label if used by a prescriber.

• Outcomes: modest objective gains; better subjective sleep for some patients.
• Patient challenges: variable benefit, occasional daytime somnolence, concerns about product quality.

Indications and expanded uses: MHRA-approved and off-label practice

When is melatonin used in UK clinical practice?

MHRA licensing in the UK is product-specific and therefore varies by formulation.

Circadin 2 mg prolonged-release is licensed for primary insomnia in patients aged 55 and over.

Many melatonin products sold elsewhere remain unlicensed in the UK and would be used off-label only under clinical supervision.

Commonly encountered indications include primary insomnia in older adults, jet lag, shift-work disorder and delayed sleep phase syndrome.

Specialist use includes adjunctive management in neurodevelopmental disorders under paediatric or psychiatric care.

Off-label NHS and private uses include short courses for acute insomnia and circadian re-entrainment protocols.

Sleepose 20 Tablet DT is not licensed in the UK.

Composition and brand landscape: active ingredients, UK brands and generics

What is in Sleepose and how does it compare to UK options?

Sleepose 20 Tablet DT contains melatonin as the active ingredient at 20 mg per disintegrating tablet.

In the UK, Circadin 2 mg prolonged-release is the main licensed melatonin product.

Prescription hypnotics such as zopiclone and zolpidem are used by the NHS when appropriate, with different risk profiles.

Contraindications and special precautions: high-risk groups and daily life restrictions

Who should avoid melatonin or take extra care?

Absolute contraindications listed for Sleepose include pregnancy and breastfeeding, and autoimmune disease contexts.

UK practice echoes caution for these groups and advises specialist review where needed.

Elderly patients need careful assessment due to increased fall risk and daytime somnolence.

Children require paediatric specialist direction and should not use melatonin without specialist prescription.

People with significant hepatic impairment require review because melatonin metabolism may be altered.

Practical daily-life restrictions include avoiding driving or operating machinery until the effect on alertness is known.

Alcohol should be minimised as it potentiates sedative effects.

Interactions with anticoagulants, immunosuppressants and certain antidepressants require clinician review before starting melatonin.

• Absolute contraindications: pregnancy, breastfeeding, autoimmune disease contexts.
• Key precautions: elderly, children, hepatic impairment, concomitant sedatives.

Dosage guidelines: standard NHS regimens and adjustments

What doses are used in the UK and when should they be adjusted?

NHS guidance prioritises the lowest effective dose for the shortest duration possible.

For licensed Circadin the dose is 2 mg at night for patients aged 55 and over.

For indications such as jet lag and delayed sleep phase, clinicians commonly use 0.5–5 mg timed to circadian phase.

Sleepose 20 Tablet DT at 20 mg is substantially higher than typical UK doses and would usually be outside standard NHS dosing.

Dose adjustments include reducing dose or avoiding melatonin in the elderly when daytime sedation is problematic.

Hepatic impairment often prompts specialist review and possible dose alteration.

Children should not receive melatonin without paediatric specialist prescription and monitoring.

Interactions overview: food, drink, and MHRA Yellow Card reports

What should clinicians and patients watch for?

Melatonin has pharmacodynamic interactions with other sedatives, increasing CNS depression.

CYP1A2 modulators can alter melatonin pharmacokinetics, with inhibitors increasing melatonin levels.

Alcohol increases sedative effects and should be avoided around dosing.

Caffeine and nicotine late in the evening may blunt melatonin’s effectiveness.

Reported adverse effects include increased daytime drowsiness and occasional mood changes; serious adverse drug reactions are rare.

For high-dose products such as Sleepose 20 Tablet DT, higher melatonin exposure increases the theoretical risk of interactions.

Clinicians should review concomitant anticoagulants, immunosuppressants and antidepressants, especially MAOIs and some SSRIs.

Comparable medicines and prescribing preferences: NHS choices and pros/cons

How does melatonin compare with other sleep medicines used in the NHS?

NHS alternatives include non-drug approaches such as CBT‑I, sedating antihistamines for short-term use and prescription hypnotics when clinically appropriate.

Z-drugs such as zopiclone and zolpidem are prescribed selectively, with attention to dependence and next-day impairment.

Circadin is preferred when a licensed melatonin product is chosen for older adults because of its licence and specific formulation.

Pros of melatonin include a generally favourable side-effect profile at low doses and usefulness for circadian disorders.

Cons include limited efficacy in chronic insomnia, variable product quality for unlicensed supplements and potential daytime drowsiness at higher doses such as 20 mg.

FAQ: common NHS patient questions and concise answers

• Is melatonin available on the NHS? Only specific licensed products such as Circadin for people aged 55 and over are routinely prescribed; other products may need specialist recommendation.
• Will melatonin make me sleepy in the day? Daytime somnolence can occur, especially at higher doses; avoid driving until you know how it affects you.
• How long before bedtime should I take it? Timing depends on the formulation; for sleep onset, short-acting melatonin is typically taken 30–60 minutes before bed. Circadian protocols vary.

Guidelines for proper use: pharmacist counselling and NHS patient support

How should pharmacists counsel patients who ask about Sleepose or melatonin?

Counselling should confirm the indication and check for pregnancy or breastfeeding.

Pharmacists must review concomitant medications including anticoagulants and antidepressants.

Advise patients to start on a low dose and to be cautious about driving and alcohol around dosing.

Provide sleep hygiene education and suggest CBT‑I referral if insomnia persists beyond four weeks.

For unlicensed products such as Sleepose 20 Tablet DT, pharmacists should recommend GP or specialist review.

Signpost NHS resources such as NHS.uk sleeplessness pages and local sleep clinics for ongoing support.

• Counselling checklist: confirm indication, check contraindications, review interactions, advise on timing, warn about driving and alcohol, provide follow-up.
• When to refer: persistent insomnia, children needing melatonin, complex polypharmacy or hepatic impairment.

Delivery across the United Kingdom